Abbott Laboratories Shares Fall Amid Earnings Beat and Exact Sciences Acquisition Impact
Abbott Laboratories (ABT) shares fell 3.2% after the company reported slightly better-than-expected first-quarter earnings, but warned of a $0.20 per share earnings dilution due to its $23 billion acquisition of Exact Sciences. The acquisition is expected to impact 2026 earnings guidance, despite long-term growth confidence.
Topics: acquisition dilution earnings financial outlook stock price movement